Accurate, balanced evidence-based information about medicines
Email this page
Print
Bookmark and share
Bigger
SmallerNPS RADAR March 2010 NPS RADAR March 2010
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| Nebivolol (Nebilet) for chronic heart failure NPS RADAR>Review>Health Professional Publication | Nebivolol is an alternative to bisoprolol, carvedilol, and controlled-release metoprolol but has less robust evidence of survival benefit. |
| Methylnaltrexone injection (Relistor) for opioid-induced constipation in palliative care NPS RADAR>Review>Health Professional Publication | Methylnaltrexone is an option for treating opioid-induced constipation in people receiving palliative care who have not responded to adequately titrated laxatives. About half of these people will have a bowel movement within 4 hours of a single dose. |
| Authority listing for terbinafine extended to children and adolescents NPS RADAR>Brief Item>Health Professional Publication | Authority listing for terbinafine extended to children and adolescents. |
| Albendazole (Zentel) listing extended to treat hookworm and strongyloidiasis NPS RADAR>Brief Item>Health Professional Publication | Strongyloidiasis and hookworm are common in tropical regions including Aboriginal and Torres Strait Islander communities in northern Australia. Albendazole is the treatment of choice for hookworm. Ivermectin is first choice for strongyloidiasis but albendazole is an alternative for those in whom ivermectin is unsuitable. |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2010-03-01 00:00:00
The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of clinical circumstances of each patient.
RSS feed
